PAR 5.13% 20.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-3952

  1. 624 Posts.
    lightbulb Created with Sketch. 258
    oxxa23, did you ever hear back from the company on your query with regard to sitting the FDA in Q4 2023 or the youtube revised Q1 2024 please?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.